User login
Article Type
Changed
Mon, 11/18/2024 - 14:45
See how pilot programs at an academic center and a community hospital demonstrated how an AI-powered screening tool better identifies candidates for bronchoscopic lung volume reduction (BLVR). The result is improved access and accelerated time to intervention for patients with severe emphysema, as well as lowered burdens on healthcare systems.
This article is in collaboration with CHEST.
Click here to read more
Sponsor
Developed under the direction and sponsorship of Olympus America.
Publications
Sponsor
Developed under the direction and sponsorship of Olympus America.
Sponsor
Developed under the direction and sponsorship of Olympus America.
See how pilot programs at an academic center and a community hospital demonstrated how an AI-powered screening tool better identifies candidates for bronchoscopic lung volume reduction (BLVR). The result is improved access and accelerated time to intervention for patients with severe emphysema, as well as lowered burdens on healthcare systems.
This article is in collaboration with CHEST.
Click here to read more
See how pilot programs at an academic center and a community hospital demonstrated how an AI-powered screening tool better identifies candidates for bronchoscopic lung volume reduction (BLVR). The result is improved access and accelerated time to intervention for patients with severe emphysema, as well as lowered burdens on healthcare systems.
This article is in collaboration with CHEST.
Click here to read more
Publications
Publications
Article Type
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Information from Industry-Sponsored Content
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Activity Salesforce Deliverable ID
398844.2